Proton Beam Therapy


Title: Stereotactic Body Radiotherapy and Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
Presenter: Laura Dawson, MD, FRCPC, FASTRO
Presenter: Smith “Jim” Apisarnthanarax, MD
Moderator: Theodore Hong, MD
Date: Wednesday, February 15, 2017
Time: 12:00pm ET / 9:00am PT
Where: Your Computer and/or Telephone
This webinar will review the use of SBRT and proton therapy for treatment of hepatocellular carcinomas. Review of the published literature as well as practical and technical issues related to both treatment modalities will be covered. Open discussions will be encouraged by participants who have interest in integrating these treatment modalities into their clinical practice of treating hepatocellular carcinoma.

After attending this activity, participants should be able to understand and describe:
    • The expanding role of radiation therapy for hepatocellular carcinoma.
    • Suitability of patients for SBRT and proton therapy for hepatocellular carcinoma.
    • Risk factors for toxicity post hepatocellular carcinoma.
    • How to personalize SBRT for hepatocellular carcinoma.
    • Potential advantages of proton therapy for hepatocellular carcinoma.
    • Clinical outcomes and toxicities with proton therapy for hepatocellular carcinoma.
    • Technical challenges and limitations of proton therapy for hepatocellular carcinoma.
Presenters and Moderator

Laura Dawson, MD, FRCPC, FASTRO, is a radiation oncologist at the Princess Margaret Cancer Centre, and a Professor the Department of Radiation Oncology, University of Toronto. She is an international leader in hepatobiliary and liver metastases radiation therapy and in the use of advanced radiation technologies such as stereotactic body radiation therapy. She is the principal investigator of several phase III clinical trials, including RTOG1112, an randomized trial of SBRT for locally advanced hepatocellular carcinoma. She has published over 150 scientific papers and has received numerous grants for her research.

Smith “Jim” Apisarnthanarax, MD, is an Associate Professor at the University of Washington (UW) / Seattle Cancer Care Alliance (SCCA) with expertise in gastrointestinal cancers. He specializes in hepatobiliary cancers, proton therapy, and stereotactic body radiation therapy. He completed a research fellowship focused on functional imaging in Radiation Oncology at the MD Anderson Cancer Center. He was on faculty at the University of Pennsylvania prior to joining the UW Department of Radiation Oncology. He serves as the Proton Therapy Fellowship Director at the UW/SCCA Proton Therapy Center.

Theodore Hong, MD, Director of Gastrointestinal Radiation Oncology at Massachusetts General Hospital and Associate Professor of Radiation Oncology at Harvard Medical School. He has published over 130 articles, and serves as the Principal Investigator of two national trials evaluating radiation in liver tumors. He is the Principal Investigator of a NIH-funded, multi-institutional grant evaluating proton therapy.

Live Webinars are free to anyone interested in learning about SRS/SBRT. Please note the following: 
    • Access to recorded webinars is limited to RSS members only.
    • CMEs for attending live webinar broadcasts are available to physicians and are at no cost to RSS physician members.
    • CMEs for attending live broadcasts are available to physicians that are non-RSS members for $12.95. 
    • For purposes of documenting CME attendance, each person must register individually and attend the entire broadcast. Certificates of Attendance will be issued based on these registration requirements, no exceptions.

CME Live Activity Overview (Physicians Only)

To be eligible for documentation of CME credit, physicians must attend the entire live webinar and complete an evaluation form. All physician attendees will be contacted after the live webinar with CME evaluation information and any associated fee. Although we cannot provide CE at this time for all medical professionals due to limited staffing and financial resources, we are currently working with organizations to offer CE in the future.

For questions regarding this educational activity, please call 408.385.9411.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AMEDCO and the Radiosurgery Society (the RSS). AMEDCO is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

AMEDCO designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Member login  

the RSS would like to
acknowledge and thank our 
Corporate Sponsors.


the RSS would like to 
acknowledge and thank our 
Academic & Hospital and
Free-Standing & Private Practice

the RSS is pleased to collaborate with the following:

Interact With Us!
facebook Like our Facebook Page   
Join our Facebook Group
twiter Follow us on Twitter 
Follow our Group on LinkedIn
Visit our Journal on Cureus
Skype Me™!  Call us on Skype